Turn Biotechnologies Signs Global Licensing Agreement with HanAll Biopharma to Develop Eye and Ear Therapies

MOUNTAIN VIEW, Calif., May 28, 2024 /PRNewswire/ -- Turn Biotechnologies, a developer of novel mRNA medicines and enabling technologies, today announced an

Related Keywords

United States ,Japan ,Indonesia ,China ,Thailand ,Jim Martinez ,Hanall Biopharma ,Vittorio Sebastiano ,Sean Jeong ,Anja Krammer ,Linkedin ,Turn Biotechnologies ,Turn Bio ,New Frontier ,Epigenetic Reprogramming ,Turn Bio Co Founder Vittorio Sebastiano ,All Biopharma ,Thailand Business ,